FLUOR CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FLUOR CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.50B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $16.32B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $15.47B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $13.74B | Feb 18, 2025 |
| FY2021 | Dec 31, 2021 | $3.16B | Feb 22, 2022 |
| FY2021 | Sep 30, 2021 | $3.10B | Feb 22, 2022 |
| FY2021 | Jun 30, 2021 | $3.24B | Feb 22, 2022 |
| FY2021 | Mar 31, 2021 | $2.94B | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | $3.27B | Feb 22, 2022 |
| FY2021 | Sep 30, 2020 | $3.46B | Feb 22, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($120.00M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $574.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $477.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $355.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $454.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $410.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | ($206.05M) | Feb 22, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($51.00M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.15B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $139.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $145.00M | Feb 18, 2025 |
| FY2021 | Dec 31, 2021 | ($279.00M) | Feb 22, 2022 |
| FY2021 | Sep 30, 2021 | $40.00M | Feb 22, 2022 |
| FY2021 | Jun 30, 2021 | ($114.00M) | Feb 22, 2022 |
| FY2021 | Mar 31, 2021 | ($87.00M) | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | ($163.00M) | Feb 22, 2022 |
| FY2021 | Sep 30, 2020 | $19.00M | Feb 22, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($378.00M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $463.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $147.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $209.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($273.00M) | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | ($232.00M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | ($828.34M) | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $510.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $213.20M | Sep 25, 2020 |
| FY2012 | Dec 31, 2012 | $769.40M | Feb 20, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($387.00M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $828.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $212.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $31.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $25.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $186.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $219.02M | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | $66.90M | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $91.44M | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | ($17.48M) | Sep 25, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $164.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $106.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $75.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $75.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $113.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $180.84M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $211.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $283.11M | Sep 25, 2020 |
| FY2018 | Dec 31, 2016 | $235.90M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.24B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $9.14B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $6.97B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $6.83B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $7.09B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $7.31B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $7.97B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $7.89B | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $8.98B | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | $9.02B | Sep 25, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.24B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.95B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.94B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.79B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.39B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.03B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $1.56B | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $2.38B | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | $2.81B | Sep 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $199.00M | Feb 18, 2025 |
| FY2024 | Dec 31, 2023 | $206.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $206.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $249.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $207.37M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $508.42M | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $442.81M | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $467.27M | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | $467.92M | Sep 25, 2020 |
| FY2019 | Dec 31, 2018 | $466.45M | Sep 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.06B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.12B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $979.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $896.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $791.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.25B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.70B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $2.00B | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $2.77B | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | $3.22B | Sep 25, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.83B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $2.52B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.44B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.21B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.20B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.00B | Feb 26, 2021 |
| FY2019 | Sep 30, 2019 | $1.81B | Sep 25, 2020 |
| FY2019 | Jun 30, 2019 | $1.86B | Sep 25, 2020 |
| FY2019 | Mar 31, 2019 | $1.81B | Sep 25, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2021 | Dec 31, 2021 | (2) | Feb 22, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | (1) | Feb 22, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 22, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2021 | Dec 31, 2021 | (2) | Feb 22, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | (1) | Feb 22, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 22, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 152.05M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 169.23M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | 170.41M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 142.32M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 141.43M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 140.72M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 140.17M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 139.65M | Sep 25, 2020 |
| FY2018 | Dec 31, 2017 | 139.92M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 139.26M | Feb 20, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $28.72M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $118.07M | Feb 26, 2021 |
| FY2020 | Dec 31, 2018 | $118.73M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $118.00M | Sep 25, 2020 |
| FY2018 | Dec 31, 2016 | $118.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $125.20M | Feb 20, 2018 |
| FY2016 | Dec 31, 2014 | $126.22M | Feb 17, 2017 |
| FY2015 | Dec 31, 2013 | $78.72M | Feb 18, 2016 |
| FY2014 | Dec 31, 2012 | $128.65M | Feb 18, 2015 |
| FY2013 | Dec 31, 2011 | $87.68M | Feb 18, 2014 |